The Effects of ProFoveate on Reducing Self-Stimulating Behaviors

Status Terminated

Clinical Trial Summary

This study is designed to pilot an intervention technique to reduce the self-stimulating behaviors seen in individuals with autism spectrum disorders using intervention with ProFoveate pellets. Self-stimulating behaviors like hand flapping, eye blinking, and rocking, can interfere with the individual's ability to interact with their peers. Participants will wear the pellets for four week and measures with taken again. Another group of participants will not get the pellets. Both groups will be tested at the beginning and end of the study. Any variations in self-stimulating behaviors will be documented through parent report, Observational data. The investigators hypothesize that they will see changes in self- stimulating behaviors as a result of the strategic placement of the ProFoveate™ pellets on the ears of one group of the participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Autism Spectrum Disorder
Autism Spectrum Disorders
Autistic Disorder
Child Development Disorders, Pervasive
Exhibit Self- Stimulating or Ritualistic Behaviors
Normal Hearing
Normal Intelligence

Clinical Trial Details

NCT number	NCT02088047
Study type	Interventional
Source	University of Arkansas
Contact
Status	Terminated
Phase	N/A
Start date	August 30, 2014
Completion date	October 4, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02625116` - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting	`NCT06381856` - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting	`NCT02280746` - Gluten for Autism Spectrum Disorders	N/A
Completed	`NCT01945957` - Brain Imaging of Intranasal Oxytocin Treatment in Autism	Phase 1
Completed	`NCT01661855` - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD	Phase 2
Completed	`NCT01691066` - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder	N/A
Completed	`NCT01694667` - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder	Phase 2
Completed	`NCT01592747` - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine	Phase 2
Completed	`NCT01780090` - Handheld Technology for Speech Development in Students With Autism	N/A
Active, not recruiting	`NCT01417026` - Intranasal Oxytocin and Learning in Autism	Phase 2
Enrolling by invitation	`NCT01364818` - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment	N/A
Completed	`NCT01695200` - Omega-3 Fatty Acids in Autism Spectrum Disorders	Phase 4
Completed	`NCT02300597` - Internet-based Support for Young People With ADHD and Autism - a Controlled Study	N/A
Completed	`NCT01675414` - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)	N/A
Not yet recruiting	`NCT00695812` - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age	N/A
Recruiting	`NCT05910502` - Project AFECT (Autism Family Empowerment Coaching and Training Program)	N/A
Completed	`NCT02081027` - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders	Early Phase 1
Completed	`NCT02797379` - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders	N/A
Terminated	`NCT01730079` - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed	`NCT01603225` - Transcranial Direct Current Stimulation and Autism